Home | Welcome to Contract Pharma   
Last Updated Thursday, July 24 2014
Print RSS Feed

Search Results for 'biopharma'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

Kemwell
By James Bannister, Director Business Development
Kemwell Biopharma is contract provider of CMC services to the pharmaceutical industry. With locations in the U.S., Bangalore India, and Uppsala Sweden, Kemwell offers services ranging from Clinical (CTM) Manufacturing, Commercial Manufacturing, Formu… Read More »
Published January 2, 2013
Resumes Abbott’s research-based business Read More »
Virus Safety of Biopharmaceuticals
By Hazel Aranha, Ph.D.
Published November 14, 2011
Absence of evidence is not evidence of absence Read More »
Published April 27, 2009
Novozymes Biopharma has begun construction of a new cGMP facility at its existing site in Tianjin, China, enabling the company to produce Bacillus-based Hyaluronic Acid (bHA), HyaCare, for the bio-medical and pharmaceutical industries. Read More »
Published March 18, 2008
Gary M. Clark, Ph.D., has joined Array BioPharma, Inc. as vice president of biostatistics and data management. Dr. Clark will oversee the company's biostatistics and data management activities on its growing pipeline of targeted small molecule drugs… Read More »
Published August 29, 2007
PDL BioPharma, Inc., following a business and portfolio review, has changed its strategic focus to the discovery and development of novel antibodies in oncology and select immunological diseases. According to a company statement, it will realign its… Read More »
Published December 13, 2006
Holmes Biopharma, Inc. has signed a letter of intent to purchase an existing pharmaceutical development, clinical manufacture, biotechnology, and analytical laboratory business located in the eastern U.S. The name and terms of the acquisition will be… Read More »
Published July 7, 2006
PDL BioPharma, Inc. plans to move its corporate headquarters from Fremont to Redwood City, CA during the third quarter of 2007. PDL has signed long-term leases for two existing buildings that total approximately 450,000 sq.-ft. The new headquarters w… Read More »
Published March 8, 2006
PDL BioPharma, Inc. has named Andrew Guggenhime senior vice president and chief financial officer. Mr. Guggenhime will join the company's senior management team reporting directly to chief executive officer Mark McDade, and will be responsible for al… Read More »
By Kristin Brooks
Published February 14, 2014
To provide preclinical drug development through to Phase I - IV trials Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On